How Research Peptides Are Made: A Look at Solid-Phase Synthesis

Most short peptides sold for laboratory work are built one amino acid at a time on a tiny plastic bead. The method is called solid-phase peptide synthesis, often shortened to SPPS, and Bruce Merrifield introduced it in the early 1960s. The core idea is simple: anchor the first amino acid to an insoluble resin, then add the rest in sequence while washing away everything that did not react.

Building the chain

Each amino acid carries a temporary protecting group on its alpha-amine, usually Fmoc, so that coupling happens at the intended position and nowhere else. A cycle looks like this: deprotect the amine, wash, activate the next amino acid, couple it, wash again. Repeat until the sequence is complete. Because the growing chain stays bolted to the resin, reagents can be added in excess and then rinsed off, which is what makes the whole approach practical to automate.

Side-chain reactive groups carry their own protecting groups that stay on until the very end. This layered protection scheme is the reason a synthesizer can assemble a twenty-residue chain without scrambling the structure.

Cleavage and what comes off with the peptide

When the sequence is finished, a cleavage cocktail releases the peptide from the resin and strips the side-chain protecting groups at the same time. Trifluoroacetic acid is the workhorse reagent here, which is why TFA frequently turns up later as a residual solvent on a certificate of analysis. Scavengers are added to mop up reactive fragments so they do not modify the peptide.

The crude material that drops out of this step is not pure. It contains the target sequence plus a family of related impurities: chains missing a residue, chains where a coupling stalled, and small amounts of modified species. Separating the target from these is the job of preparative chromatography, and the success of that separation is what you read about later in an HPLC purity figure.

Why the route matters for analysis

The synthesis route leaves fingerprints. Deletion sequences differ from the target by one residue, so they show up as closely eluting peaks in reverse-phase HPLC. Confirming that the main peak is actually the intended molecule, rather than a near-identical impurity, is where mass spectrometry earns its place, since it reports the molecular mass directly.

A few practical points about synthesized material:

• Longer sequences are harder to assemble cleanly, so impurity counts tend to climb with chain length.
• Residual TFA and synthesis solvents are expected and are quantified, not assumed to be absent.
• The counterion present after purification (often acetate or TFA salt) affects the reported peptide content.

None of this speaks to what a peptide does. In the published literature, individual sequences have been examined in preclinical in-vitro and animal-model studies under experimental conditions, and that work is entirely separate from the chemistry of making the molecule. The synthesis story is about identity and composition: what was built, and how cleanly.

Common questions

Is SPPS the only way peptides are made? No. Recombinant expression and solution-phase chemistry exist, but SPPS dominates for the short sequences typical of research catalogs because it is fast and automatable.

This article is provided for educational purposes and describes areas of scientific investigation only. Products referenced are intended for laboratory and research use only and are not for human consumption.